MCID: OST115
MIFTS: 41

Osteonecrosis of the Jaw

Categories: Oral diseases, Bone diseases, Rare diseases

Aliases & Classifications for Osteonecrosis of the Jaw

MalaCards integrated aliases for Osteonecrosis of the Jaw:

Name: Osteonecrosis of the Jaw 55

Classifications:



External Ids:

Orphanet 55 ORPHA399293
UMLS via Orphanet 70 C2711248
ICD10 via Orphanet 33 K10.2

Summaries for Osteonecrosis of the Jaw

MalaCards based summary : Osteonecrosis of the Jaw is related to osteonecrosis and arthritis. An important gene associated with Osteonecrosis of the Jaw is CYP2C8 (Cytochrome P450 Family 2 Subfamily C Member 8), and among its related pathways/superpathways are Allograft rejection and Defensins. The drugs Alendronate and Zoledronic acid have been mentioned in the context of this disorder. Affiliated tissues include bone, prostate and breast.

Wikipedia : 72 Osteonecrosis of the jaw (ONJ) is a severe bone disease (osteonecrosis) that affects the jaws (the... more...

Related Diseases for Osteonecrosis of the Jaw

Diseases related to Osteonecrosis of the Jaw via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 95)
# Related Disease Score Top Affiliating Genes
1 osteonecrosis 32.0 CYP2C8 FDPS VEGFA
2 arthritis 30.0 HLA-DQB1 HLA-DRB1 IL17A
3 rheumatoid arthritis 30.0 HLA-DQB1 HLA-DRB1 IL17A VEGFA
4 periodontal disease 29.9 DEFB1 DEFB4A IL17A
5 bone mineral density quantitative trait locus 8 10.4
6 bone mineral density quantitative trait locus 15 10.4
7 osteoporosis 10.4
8 limbic encephalitis with lgi1 antibodies 10.3 HLA-DQB1 HLA-DRB1
9 central nervous system vasculitis 10.3 HLA-DRB1 IL17A
10 metal allergy 10.3 HLA-DQB1 HLA-DRB1
11 focal epithelial hyperplasia 10.3 HLA-DQB1 HLA-DRB1
12 myeloma, multiple 10.3
13 beryllium disease 10.3 HLA-DQB1 HLA-DRB1
14 lichen planopilaris 10.3 HLA-DQB1 HLA-DRB1
15 type ii mixed cryoglobulinemia 10.3 HLA-DQB1 HLA-DRB1
16 idiopathic inflammatory myopathy 10.3 HLA-DQB1 HLA-DRB1
17 recurrent respiratory papillomatosis 10.3 HLA-DQB1 HLA-DRB1
18 chronic beryllium disease 10.3 HLA-DQB1 HLA-DRB1
19 autoimmune pancreatitis 10.3 HLA-DQB1 HLA-DRB1
20 pityriasis rosea 10.3 HLA-DQB1 HLA-DRB1
21 lichen sclerosus 10.3 HLA-DQB1 HLA-DRB1
22 whipple disease 10.3 HLA-DQB1 HLA-DRB1
23 acute disseminated encephalomyelitis 10.3 HLA-DQB1 HLA-DRB1
24 pediatric multiple sclerosis 10.3 HLA-DQB1 HLA-DRB1
25 microscopic colitis 10.2 HLA-DQB1 HLA-DRB1
26 idiopathic bronchiectasis 10.2 HLA-DQB1 HLA-DRB1
27 peanut allergy 10.2 HLA-DQB1 HLA-DRB1
28 oligoarticular juvenile idiopathic arthritis 10.2 HLA-DQB1 HLA-DRB1
29 hemorrhagic fever with renal syndrome 10.2 HLA-DRB1 SEMA4D
30 periodontitis 10.2
31 hypersomnia 10.2 HLA-DQB1 HLA-DRB1
32 neuromyelitis optica 10.2 HLA-DRB1 IL17A
33 severe hemophilia a 10.2 HLA-DQB1 HLA-DRB1
34 juvenile nasopharyngeal angiofibroma 10.2 CYP19A1 VEGFA
35 endophthalmitis 10.2 DEFB1 VEGFA
36 ocular cicatricial pemphigoid 10.1 HLA-DQB1 HLA-DRB1
37 geographic tongue 10.1 HLA-DQB1 HLA-DRB1 VEGFA
38 prostatitis 10.1
39 cystic echinococcosis 10.1 HLA-DQB1 HLA-DRB1 IL17A
40 panuveitis 10.1 HLA-DQB1 HLA-DRB1 IL17A
41 vogt-koyanagi-harada disease 10.1 HLA-DQB1 HLA-DRB1 IL17A
42 corneal abscess 10.1 DEFB1 DEFB4A
43 osteomyelitis 10.0
44 episodic pain syndrome, familial, 1 10.0
45 thrombophilia 10.0
46 paraneoplastic pemphigus 10.0 HLA-DQB1 HLA-DRB1
47 vulvovaginal candidiasis 10.0 DEFB1 DEFB4A
48 oral candidiasis 10.0 DEFB1 DEFB4A
49 endotheliitis 10.0
50 crohn's disease 10.0

Graphical network of the top 20 diseases related to Osteonecrosis of the Jaw:



Diseases related to Osteonecrosis of the Jaw

Symptoms & Phenotypes for Osteonecrosis of the Jaw

Drugs & Therapeutics for Osteonecrosis of the Jaw

Drugs for Osteonecrosis of the Jaw (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 57)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alendronate Approved Phase 4 121268-17-5, 66376-36-1 2088
2
Zoledronic acid Approved Phase 4,Phase 3 118072-93-8 68740
3 Diphosphonates Phase 4,Phase 3,Phase 1
4 Bone Density Conservation Agents Phase 4,Phase 3,Phase 1
5 Hormones Phase 4
6
Gemcitabine Approved Phase 3 95058-81-4 60750
7
Denosumab Approved Phase 3 615258-40-7
8
Pentoxifylline Approved, Investigational Phase 3 6493-05-6 4740
9 Tocopherol Approved, Investigational, Nutraceutical Phase 3
10
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
11
Docetaxel Approved May 1996, Investigational Phase 3 114977-28-5 148124 9877265
12 Mitogens Phase 2, Phase 3
13 Tocopherols Phase 3
14 Tocotrienols Phase 3
15 Micronutrients Phase 3
16 Trace Elements Phase 3
17 Vasodilator Agents Phase 3
18 Vitamins Phase 3
19 Phosphodiesterase Inhibitors Phase 3
20 Platelet Aggregation Inhibitors Phase 3
21 Protective Agents Phase 3
22 Radiation-Protective Agents Phase 3
23 Antioxidants Phase 3
24 Tocotrienol Investigational, Nutraceutical Phase 3 6829-55-6
25
Amoxicillin Approved, Vet_approved 26787-78-0 33613 2171
26
Clindamycin Approved, Vet_approved 18323-44-9 29029
27
Phenytoin Approved, Vet_approved 57-41-0 1775
28
Tetracycline Approved, Vet_approved 60-54-8 5353990
29
Menthol Approved 2216-51-5 16666
30
Pamidronate Approved 40391-99-9 4674
31
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
32
Etidronic acid Approved 2809-21-4, 7414-83-7 3305
33
Teriparatide Approved, Investigational 52232-67-4 16133850
34
tiludronate Approved, Investigational, Vet_approved 89987-06-4 60937
35
Sunitinib Approved, Investigational 341031-54-7, 557795-19-4 5329102
36
Cholecalciferol Approved, Nutraceutical 67-97-0 10883523 5280795 6221
37 Clavulanic Acid
38 Clindamycin palmitate
39 Clindamycin phosphate
40 Amoxicillin-Potassium Clavulanate Combination
41 Anti-Bacterial Agents
42 Anti-Infective Agents
43 Antibiotics, Antitubercular
44 beta-Lactamase Inhibitors
45 Antitubercular Agents
46 Sodium Channel Blockers
47 Diuretics, Potassium Sparing
48 Anticonvulsants
49 Risedronate Sodium 115436-72-1
50 Disinfectants

Interventional clinical trials:

(show all 30)

# Name Status NCT ID Phase Drugs
1 Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases Completed NCT00434447 Phase 4 Zoledronic acid
2 Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study Completed NCT02139007 Phase 4 Alendronate
3 Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial Completed NCT02181101 Phase 3 FEC-DocGemzar adjuvant chemotherapy;FEC-Doc adjuvant chemotherapy;Zoledronic acid i.v. 2 years;Zoledronic acid i.v. 5 years
4 Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks Recruiting NCT02051218 Phase 3 Denosumab (reduced dosing);Denosumab (standard dosing)
5 Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Active, not recruiting NCT00869206 Phase 3 zoledronic acid
6 Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) Not yet recruiting NCT03040778 Phase 3 Pentoxifylline;Placebo;Tocopherol
7 Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw Not yet recruiting NCT03390777 Phase 2, Phase 3
8 Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates Completed NCT00462098 Phase 1
9 Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis Recruiting NCT02566681 Phase 1
10 Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay Unknown status NCT02218554
11 Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction Unknown status NCT02198001 tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine)
12 CONDOR Study of Osteonecrosis of the Jaws (TMJ) Completed NCT01130389
13 Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer Completed NCT01325142
14 Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw Completed NCT01998607
15 DPBRN Retrospective Cohort Study of Osteonecrosis of the Jaw Completed NCT01201330
16 Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis Completed NCT00601068
17 Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible Completed NCT03269214 Topical Phenytoin 5%
18 Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging Completed NCT00592982
19 Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC Completed NCT01062503 Zoledronic acid
20 Medication-related Osteonecrosis of the Jaw (MRONJ) Registry Recruiting NCT02932501
21 The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw Recruiting NCT03418454
22 Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use Recruiting NCT01875458
23 Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction Recruiting NCT02661139
24 HBOT Late Radiation Tissue Injury Recruiting NCT02425215
25 Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques Recruiting NCT02747173
26 Osteonecrosis of the Jaw (ONJ) Case Registry Active, not recruiting NCT01666106
27 Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid Active, not recruiting NCT01967160
28 S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Active, not recruiting NCT00874211
29 Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study Active, not recruiting NCT00858585
30 Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid Withdrawn NCT02069340 zoledronic acid

Search NIH Clinical Center for Osteonecrosis of the Jaw

Genetic Tests for Osteonecrosis of the Jaw

Anatomical Context for Osteonecrosis of the Jaw

MalaCards organs/tissues related to Osteonecrosis of the Jaw:

38
Bone, Prostate, Breast, Bone Marrow, T Cells, Endothelial, Myeloid

Publications for Osteonecrosis of the Jaw

Articles related to Osteonecrosis of the Jaw:

(show top 50) (show all 408)
# Title Authors Year
1
Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review. ( 29225245 )
2018
2
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. ( 29365278 )
2018
3
Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw. ( 29224060 )
2018
4
Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone. ( 29211870 )
2018
5
Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw. ( 29249520 )
2018
6
Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study. ( 29435826 )
2018
7
Preventive dental management of osteonecrosis of the jaws related to zoledronic acid treatment. ( 29412504 )
2018
8
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis. ( 29289789 )
2018
9
Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics. ( 29325851 )
2018
10
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function. ( 29408511 )
2018
11
Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions. ( 29432652 )
2018
12
Early removal of sequestrum in patients affected by medication-related osteonecrosis of the jaw. ( 29422306 )
2018
13
Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review. ( 29325766 )
2018
14
Effect of different doses and durations of teriparatide therapy onA resolution of medication-related osteonecrosis of the jaw: AA randomized, controlled preclinical study in rats. ( 29395991 )
2017
15
In Reply-Bisphosphonates and Osteonecrosis of the Jaw. ( 28688472 )
2017
16
Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. ( 27856150 )
2017
17
Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review. ( 27876532 )
2017
18
Cross-Sectional Study of four Serological Bone Turnover Markers for the Risk Assessment of Medication-Related Osteonecrosis of the Jaw. ( 29215447 )
2017
19
Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark. ( 28941210 )
2017
20
Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics. ( 28809382 )
2017
21
Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw. ( 28857991 )
2017
22
Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2. ( 28760314 )
2017
23
Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study. ( 29175416 )
2017
24
Phosphate buffer-stabilized 0.1% chlorine dioxide oral rinse for managing medication-related osteonecrosis of the jaw. ( 29251459 )
2017
25
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report. ( 28744112 )
2017
26
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. ( 28693379 )
2017
27
A case of bisphosphonate-related osteonecrosis of the jaw with a particularly unfavourable course: a case report. ( 28875143 )
2017
28
Histochemical observation of bony reversal lines in bisphosphonate-related osteonecrosis of the jaw. ( 27989705 )
2017
29
High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients. ( 27921521 )
2017
30
Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis? ( 28809381 )
2017
31
Dental students' knowledge of medication-related osteonecrosis of the jaw. ( 29279671 )
2017
32
Identification of predisposing factors for osteonecrosis of the jaw after marginal mandibulectomy in the surgical management of oral squamous cell carcinoma. ( 29165823 )
2017
33
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy. ( 28766109 )
2017
34
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. ( 29275525 )
2017
35
Corrigendum: Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw. ( 28770165 )
2017
36
The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ). ( 28936298 )
2017
37
Axitinib-related osteonecrosis of the jaw. ( 28918879 )
2017
38
SIRT1/HERC4 Locus Associated with Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis. ( 28856724 )
2017
39
Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study. ( 28815779 )
2017
40
Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates. ( 27918742 )
2017
41
Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review. ( 28693144 )
2017
42
Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study. ( 28869827 )
2017
43
Perimandibular abscess associated with bisphosphonate-related osteonecrosis of the jaw. ( 29264053 )
2017
44
Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis. ( 28854059 )
2017
45
Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice. ( 28902422 )
2017
46
Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental students of the Principality of Asturias (Spain). ( 29410755 )
2017
47
Insufficient evidence of superiority of any treatment for medication-related osteonecrosis of the jaw. ( 28821344 )
2017
48
The starting point for bisphosphonate-related osteonecrosis of the jaw: Alveolar bone or oral mucosa? A randomized, controlled experimental study. ( 27919595 )
2017
49
Selective Percutaneous Controlled Radiofrequency Thermocoagulation of the Gasserian Ganglion To Control Facial Pain Due to Medication-Related Osteonecrosis of the Jaw. ( 28772087 )
2017
50
Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw. ( 29266738 )
2017

Variations for Osteonecrosis of the Jaw

Expression for Osteonecrosis of the Jaw

Search GEO for disease gene expression data for Osteonecrosis of the Jaw.

Pathways for Osteonecrosis of the Jaw

GO Terms for Osteonecrosis of the Jaw

Cellular components related to Osteonecrosis of the Jaw according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.63 DEFB1 DEFB103B DEFB4A IL17A SEMA4D VEGFA
2 clathrin-coated endocytic vesicle membrane GO:0030669 9.32 HLA-DQB1 HLA-DRB1
3 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.26 HLA-DQB1 HLA-DRB1
4 MHC class II protein complex GO:0042613 8.96 HLA-DQB1 HLA-DRB1
5 Golgi lumen GO:0005796 8.8 DEFB1 DEFB103B DEFB4A

Biological processes related to Osteonecrosis of the Jaw according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 defense response to bacterium GO:0042742 9.63 DEFB1 DEFB103B DEFB4A
2 defense response GO:0006952 9.61 DEFB1 DEFB103B DEFB4A
3 defense response to Gram-positive bacterium GO:0050830 9.54 DEFB1 DEFB103B DEFB4A
4 defense response to Gram-negative bacterium GO:0050829 9.5 DEFB1 DEFB103B DEFB4A
5 antigen processing and presentation GO:0019882 9.49 HLA-DQB1 HLA-DRB1
6 killing of cells of other organism GO:0031640 9.48 DEFB103B DEFB4A
7 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002504 9.4 HLA-DQB1 HLA-DRB1
8 antimicrobial humoral response GO:0019730 9.33 DEFB1 DEFB103B DEFB4A
9 humoral immune response mediated by circulating immunoglobulin GO:0002455 9.26 HLA-DQB1 HLA-DRB1
10 immune response GO:0006955 9.1 DEFB1 DEFB4A HLA-DQB1 HLA-DRB1 IL17A SEMA4D
11 immunoglobulin production involved in immunoglobulin mediated immune response GO:0002381 8.96 HLA-DQB1 HLA-DRB1

Molecular functions related to Osteonecrosis of the Jaw according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 9.26 HLA-DQB1 HLA-DRB1
2 aromatase activity GO:0070330 9.16 CYP19A1 CYP2C8
3 MHC class II receptor activity GO:0032395 8.96 HLA-DQB1 HLA-DRB1
4 CCR6 chemokine receptor binding GO:0031731 8.62 DEFB1 DEFB4A

Sources for Osteonecrosis of the Jaw

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....